MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0062928
Maxheal Laboratories Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹69.71 Cr
▲ 13% YoY
Net loss · FY 2025
₹3.92 Cr
Net margin -5.6%
EBITDA · FY 2025
₹4.04 Cr
EBITDA margin 5.8%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.38 Cr
Issued & subscribed
Open charges
₹28.18 Cr
Satisfied ₹26.38 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
101
Provident fund records
About Maxheal Laboratories Private Limited
Data last updated:
Maxheal Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2004PTC150120. Its GSTIN is 27AAECM1598C1ZH (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.38 Cr. It was formerly known as Maxheal Pharmaceuticals Private Limited. It is led by directors including Hemlata Madanlal Sakhala and Madanlal Mohanlal Sakhala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹69.71 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net loss of ₹3.92 Cr (net margin -5.6%) and EBITDA of ₹4.04 Cr (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 17% over five years.
The company has about 101 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹28.18 Cr and satisfied charges of ₹26.38 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹6.34 Cr; the latest was in March 2013. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Jaahnavee Lifesciences Private Limited with revenue of ₹70.16 Cr. The company has 13 MSME Form 1 returns on record between 2019 and 2023, listing 599 overdue payments to 33 micro and small suppliers.
Maxheal Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0062928). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maxheal.in.
Company details
CIN U24230MH2004PTC150120
Registration Number 150120
Incorporation Date 21 December 2004
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0062928
Key People
Hemlata Madanlal Sakhala Director Madanlal Mohanlal Sakhala Director Mehul Madan Sakhala Director Recognitions & Rankings of Maxheal Laboratories
Contact details
Maxheal Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is maxheal.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address401 4th Floor Maxheal House Plot No. 169 Cst No. 1043 Bangur Nagar Goregaon (We, St), Mumbai, Maharashtra, India – 400090
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maxheal Laboratories Private Limited, buy the company report.
Comprehensive company report
Maxheal Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Maxheal Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Maxheal Laboratories Private Limited, buy the company report.
Financials of Maxheal Laboratories Private Limited
FY 2025 filings availableMaxheal Laboratories Private Limited reported revenue of ₹69.71 Cr (up 13% YoY) for FY 2025.
Revenue · FY 2025
₹69.71 Cr ▲ 13%
Net loss · FY 2025
₹3.92 Cr margin -5.6%
EBITDA · FY 2025
₹4.04 Cr margin 5.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 13%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▼ 20%
3 years · compounded
▲ 2%
5 years · compounded
▲ 39%
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 13% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.04 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.92 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | -5.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxheal Laboratories Private Limited, buy the company report.
Board of directors of Maxheal Laboratories Private Limited
Maxheal Laboratories has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemlata Madanlal Sakhala Also directs: Maxheal Pharmaceuticals (India) Limited | Director | 21 Dec 2004 | 21 Years 10 Months | Current |
| Madanlal Mohanlal Sakhala Also directs: Maxheal Pharmaceuticals (India) Limited | Director | 21 Dec 2004 | 21 Years 10 Months | Current |
| Mehul Madan Sakhala Also directs: Maxheal Pharmaceuticals (India) Limited | Director | 01 Apr 2006 | 20 Years 6 Months | Current |
Peer comparison
Maxheal Laboratories Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jaahnavee Lifesciences Private Limited | ₹70.16 Cr (FY 2025) | 17.0% | Hyderabad, Telangana, India | |||
| Aneta Pharmaceuticals Private Limited | ₹70.12 Cr (FY 2025) | 671.0% | Ahmedabad, Gujarat, India | |||
| Asoj Soft Caps Pvt Ltd | ₹69.74 Cr (FY 2025) | 23.0% | Mumbai, Maharashtra, India | |||
| Maxheal Laboratories Private Limitedthis company | ₹69.71 Cr (FY 2025) | -₹3.92 Cr | -5.6% | 13.0% | 101 | Mumbai, Maharashtra, India |
| Sanjivani Biochem Private Limited | ₹69.17 Cr (FY 2025) | 64.0% | Ahmedabad, Gujarat, India | |||
| Three B Healthcare Limited | ₹68.95 Cr (FY 2024) | -2.0% | New Delhi, Delhi, India | |||
| Sunglow Lifescience Private Limited | ₹68.84 Cr (FY 2025) | -2.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Maxheal Laboratories Private Limited, buy the company report.
Auditor
Maxheal Laboratories Private Limited is audited by PHIRODIA BAFNA & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PHIRODIA BAFNA & ASSOCIATES | FY 2024 | 107911W |
Shareholding
The shareholding of Maxheal Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maxheal Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹28.18 Cr
Satisfied charges
₹26.38 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 May 2023 | 100727674 | Others | ₹18.37 Lakh | Open | |
| 17 May 2022 | 100580553 | Others | ₹3 Cr | Open | |
| 01 Dec 2021 | 100513808 | Others | ₹3 Cr | Open | |
| 22 May 2015 | 10572913 | Others | ₹11 Cr | Open | |
| 03 Nov 2006 | 10026139 | Others | ₹11 Cr | Open |
To see the full charge records of Maxheal Laboratories Private Limited, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Maxheal Laboratories Private Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹6.34 Cr; the latest was in March 2013.
Total deals
4
Funding rounds
2
Secondary share transfers
2
Disclosed funding
₹6.34 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2013 | Funding round | ₹5 Cr | Investors: 2 individuals |
| Mar 2008 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Narendra Jain Huf, an individual |
| Jun 2007 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2007 | Funding round | ₹1.34 Cr | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Maxheal Laboratories Private Limited has 1 court case on record: 1 filed by Maxheal Laboratories. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Special civil application | Filed by the company against Diamond and Gem Development Corporation Limited and 4 others | Disposed |
To see the full case history of Maxheal Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Maxheal Laboratories Private Limited was last rated by Care on 20 Sep 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 20 Sep 2022 |
To see the full credit ratings and regulatory alerts of Maxheal Laboratories Private Limited, buy the company report.
MSME payment delays
Maxheal Laboratories Private Limited has 13 MSME Form 1 returns on record between 2019 and 2023, listing 599 overdue payments to 33 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 33)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Corel Pharma Chem | |||
| an individual supplier | |||
| M'lunias Biochem Overseas Private Limited | |||
| Central Drug House | |||
| Siddhivinayak Industries |
To see the full MSME payment records of Maxheal Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Maxheal Laboratories Private Limited has a workforce of 101 employees on its EPFO records as of Feb 27, 2025, across 1 active EPFO establishment.
Employee count
101
Active EPFO establishments
1
Employee growth
-6.48%
GST
Maxheal Laboratories has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECM1598C1ZH | Maharashtra | Active | 01 Jul 2017 |
| 24AAECM1598C1ZN | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maxheal Laboratories Private Limited, buy the company report.
Recent activity
Maxheal Laboratories Private Limited has 3 board changes on record since 2004: 3 appointments. The latest: Mehul Madan Sakhala was appointed as Director on 01 Apr 2006.
AGM
Maxheal Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 17 Aug 2020 via Charge ID 100398616 with Others was fully satisfied on 04 Apr 2025.
Charges
A charge registered on 24 Sep 2019 via Charge ID 100295192 with Others was fully satisfied on 04 Apr 2025.
Charges
A charge with Others of Rs. 11.00 Cr registered on 22 May 2015 with Charge ID 10572913 was modified on 04 Apr 2025.
Filing
Maxheal Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 0.18 Cr with Charge ID 100727674 was registered on 20 May 2023.
Charges
A charge registered on 08 Jun 2022 via Charge ID 100587611 with Others was fully satisfied on 14 Mar 2023.
Charges
A charge with Others amounted to Rs. 2.75 Cr with Charge ID 100587611 was registered on 08 Jun 2022.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100580553 was registered on 17 May 2022.
Charges
A charge registered on 31 Oct 2020 via Charge ID 100398615 with Others was fully satisfied on 21 Dec 2021.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100513808 was registered on 01 Dec 2021.
Charges
A charge registered on 20 May 2020 via Charge ID 100372951 with Others was fully satisfied on 01 Dec 2021.
15 earlier events are in the company report.
Frequently asked questions
Maxheal Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 December 2004 (22+ years old) and is registered under CIN U24230MH2004PTC150120.
Maxheal Laboratories has 3 current directors:
- Hemlata Madanlal Sakhala - Director
- Madanlal Mohanlal Sakhala - Director
- Mehul Madan Sakhala - Director
The latest financial statements of Maxheal Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Maxheal Laboratories is 27AAECM1598C1ZH, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAECM1598C1ZN (Gujarat).
The CIN (Corporate Identification Number) of Maxheal Laboratories is U24230MH2004PTC150120. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxheal Laboratories has 1 court case on record: 1 filed by the company.
Maxheal Laboratories was incorporated on 21 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
Maxheal Laboratories has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹6.34 Cr; the latest was in March 2013.
The peers of Maxheal Laboratories by revenue are Jaahnavee Lifesciences Private Limited, Aneta Pharmaceuticals Private Limited, Asoj Soft Caps Pvt Ltd, Sanjivani Biochem Private Limited, Three B Healthcare Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mehul Madan Sakhala was appointed as Director on 01 Apr 2006. Hemlata Madanlal Sakhala was appointed as Director on 21 Dec 2004. Madanlal Mohanlal Sakhala was appointed as Director on 21 Dec 2004.
Yes, Maxheal Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0062928).
Maxheal Laboratories has 13 MSME Form 1 returns on record between 2019 and 2023, listing 599 overdue payments to 33 micro and small suppliers. The latest return was filed on 18 Dec 2023.